BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 20, 2012
View Archived Issues
Novel FLAP inhibitors divulged by Boehringer Ingelheim
Read More
FKD Therapies clear to launch phase II Instiladrin study
Read More
Scientists in China links gene's expression levels to severity of cognitive impairment
Read More
Novel BACE inhibitor shows promise to treat Alzheimer's disease
Read More
Novel agents for hepatitis C prepared at Cocrystal Discovery
Read More
Spanish researchers patent new CB1 receptor ligands
Read More
Novel TLR7 agonists disclosed
Read More
Preclinical evaluation of OMS-824 complete
Read More
New antisense oligonucleotides designed at miRagen Therapeutics
Read More
Novel antivirals disclosed by Abbott
Read More
GSK vaccine candidate for shingles enters phase III study
Read More
MetaMax focuses on development of MM-D37K
Read More
Novel bile acid receptor agonists presented by IRM
Read More
Antinicotine gene therapy as a novel approach to nicotine addiction
Read More
Johnson & Johnson reviews highlights of second quarter 2012
Read More
NVP-BKM120 shows potential in models of follicular lymphoma
Read More
Milestone met in Amgen/Array BioPharma collaboration
Read More
Soricimed Biopharma to design biologic drug conjugates for oncology indications
Read More
FDA clears pivotal trials of sustained-release microinsert in uveitis
Read More
Phrixus Pharmaceuticals reports preclinical results for Carmeseal
Read More
Phase I trial commences of combination therapy for ovarian cancer
Read More
Phase I/II Actimab-A trial advances
Read More
Cytomedix collaborates with Duke University on brain cancer study
Read More
University of Alberta kicks off phase I/II study of pan-caspase inhibitor
Read More
NIH to test maraviroc-based drug regimens for HIV prevention
Read More
Sanofi and Regeneron launch phase III program for LDL-lowering antibody
Read More
Investigators at Bristol-Myers Squibb identify novel dAbs targeting CD40-L
Read More
